Home > SWOT Analysis > Affymax (AFFY) SWOT Analysis





Affymax (AFFY) SWOT Analysis Profile

Affymax, Inc., founded in 2001, is a biopharmaceutical company, that develops peptide-based drugs for the treatment of life-threatening conditions. One lead product, Hematide, is designed to treat anemia associated with chronic renal failure and cancer. Affymax is based in Palo Alto, California. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email